Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Disease Sites:

Neuro-Oncology

Staging:

Early Phase I

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Morone, Peter

Scope:

Local

Participating Institutions:

Vanderbilt University

Open Date:

07-07-2026

Trial Type:

Diagnostic

Protocol ID:

VICCHN25072

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available